We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

4% Recession in 2003 French Laboratory Market

By HospiMedica staff writers
Posted on 25 Feb 2004
Laboratory suppliers in France suffered a 4% recession in 2003 for the first time since the Interprofessional Committee of Laboratory Suppliers (CIFL, Paris, France) began keeping statistics on this market.

According to the CIFL, there were four main reasons for this recession. One was the freeze of credits allocated to public laboratories in 2003, and this market represents about 40% of the activity of the suppliers. Other reasons were the delocalization of numerous research centers in the pharmaceutical industry, and concerns about the upcoming Reach project in the chemical industry. Finally, the biotechnology sector cut its expenses by 5.2% in 2003, compared to 2002. The combination of these elements accounted for a decrease of 5.5% in investments linked to lab instrumentation. Over the same period, the purchase of current supplies for laboratory functioning dropped 2%.

For 2004, the CIFL anticipates a progressive decline in this sector over the next few months but is counting on its professional trade show to boost activity.





Related Links:
CIFL

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
25 Feb 2004  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
25 Feb 2004  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
25 Feb 2004  |   Industry